China Diabetes Market Report 2015-2020

Imarc

Consulting Services

www.imarcgroup.com

China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

IMARC Group Email: sales@imarcgroup.com Website: www.imarcgroup.com Phone: (US)+1-631-791-1145, (IND) 91-120-415-5099 Copyright Š 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved

Imarc

About IMARC Group

Report Description

www.imarcgroup.com

The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

China Diabetes Market: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics Driven by a large diabetic population, continuous economic growth and increasing disposable incomes, the diabetes market - Non-Insulin Anti-diabetics, Insulin and Diabetes Diagnostics is witnessing double digit growth rates.

As the second largest economy of the world, China enjoys pink of health but its affluence is giving rise to another sickness - a rapid increase in a life-style disease called diabetes. With the Chinese population getting richer, fatter and less mobile, there has been a surge in the prevalence of diabetes. With a prevalence rate of around 12 percent in the adult population, China currently represents the diabetes capital of the world.

The rising prevalence of diabetes, however, is catalysing the market for diabetes products in the country. Driven by a continuous economic growth and increasing disposable incomes, the diabetes market - Non-Insulin Antidiabetics, Insulin and Diabetes Diagnostics is witnessing double digit growth rates and creating lucrative opportunities for global pharmaceutical and diagnostic companies at a time when growth rates in the more developed markets have declined.

IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics� provides an analytical and statistical insight into the Chinese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Chinese diabetes market in any form.

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

What we have achieved in this report: Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:

Focus of the Analysis: • • • • • • •

Historical, current and future prevalence of diabetes in China Historical, current and future prevalence of type-1 and type-2 diabetes in China Historical, current and future prevalence of diabetes in the urban and rural regions in China Historical, current and future prevalence of diabetes among males and females in China Historical, current and future prevalence of diabetes among various age groups in China Historical, current and future diagnosis rates for diabetes in China Historical, current and future drug treatment rates for diabetes in China

Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:

Focus of the Analysis: • • • •

Performance of the Oral Antidiabetics market in China Performance of key classes Performance of key players Market outlook

Imarc

China Diabetes Market

Report Description

www.imarcgroup.com

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Comprehensive situation analysis of the Chinese Insulin market and its dynamics: Focus of the Analysis: • • • •

Performance of the Insulin market in China Performance of key classes Performance of key players Market outlook

Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:

Focus of the Analysis: • • • •

Performance of the diabetes diagnostics market in China Market segmentation Key players Market outlook

Table of Contents 1 Research Methodology 2 Executive Summary 3 Diabetes Disease Overview 3.1 What is Diabetes?

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

3.2 Diabetes Diagnosis and Treatment 3.2.1 Diagnosis 3.2.2 Treatment 3.3 Diabetes Complications 4 Key Factors Driving the Diabetes Market in China 5 China Diabetes Epidemiology 5.1 Diabetes Population and Prevalence Rates 5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2) 5.3 Population and Prevalence Rates by Region 5.4 Population and Prevalence Rates by Gender 5.5 Population and Prevalence Rates by Age Group 5.6 Diabetes Diagnosis and Drug Treatment Rates 6 China Diabetes Market 6.1 Historical Market Trends (2007-2014) 6.2 Market Breakup by Segment (2007-2014) 6.3 China Oral Antidiabetics Market 6.3.1 Historical Market Trends (2007-2014) 6.3.2 Market Breakup by Class (2007-2014) 6.3.3 Market Shares of Key Players 6.3.4 Market Outlook (2015-2020) 6.4 China Insulin Market 6.4.1 Historical Market Trends (2015-2020) 6.4.2 Market Breakup by Class 6.4.3 Market Shares of Key Players

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

6.4.4 Market Outlook (2015-2020) 6.5 Market Outlook (2015-2020) 7 China Diabetes Diagnostics Market 7.1 Historical Market Trends (2007-2014) 7.2 Market Segmentation 7.3 Key Players 7.4 Market Outlook (2015-2020)

List of Figures Figure 3 1: The Impact of Diabetes on the Human Body Figure 3 2: Diabetes Complications Figure 4 1: China: Overweight & Obese Population (in Millions), 2007, 2014 & 2020 Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2014 & 2030 Figure 5 1: China: Total Number of Diabetes Patients (in Millions), 2007- 2014 Figure 5 2: China: Total Number of Diabetes Patients (in Millions), 2015 – 2020 Figure 5 3: China (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2007- 2014 Figure 5 4: China (Type1 & Type2): Total Number of Diabetes Patients (in Millions) 2015 – 2020 Figure 5 5: China (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2007- 2014 Figure 5 6: China (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2015 – 2020 Figure 5 7: China (Male & Female): Total Number of Diabetes Patients (in Millions), 2007- 2014 Figure 5 8: China (Male & Female): Total Number of Diabetes Patients (in Millions), 2015 – 2020

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Figure 5 9: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 20072014 Figure 5 10: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2015 – 2020 Figure 5 11: China: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2007- 2014 Figure 5 12: China: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2015 – 2020 Figure 6 1: China: Diabetes Market (in Million US$), 2007-2014 Figure 6 2: China: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2007-2014 Figure 6 3: China: Oral Antidiabetics Market (in Million US$), 2007-2014 Figure 6 4: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2007-2014 Figure 6 5: China: Oral Antidiabetics Market: Sales Share of Key Players (in %) Figure 6 6: China: Oral Antidiabetics Market Forecast (in Million US$), 2015-2020 Figure 6 7: China: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020 Figure 6 8: China: Insulin Market (in Million US$), 2007-2014 Figure 6 9: China: Insulin Market: Sales Share of Key Classes (in %), 2014 Figure 6 10: China: Insulin Market: Sales Share of Key Players (in %) Figure 6 11: China: Insulin Market Forecast (in Million US$), 2015-2020 Figure 6 12: China: Insulin Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020 Figure 6 13: China: Diabetes Market Forecast (in Million US$), 2015-2020 Figure 6 14: China: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020 Figure 7 1: China: Diabetes Diagnostics Market (in Million US$), 2007-2014 Figure 7 2: China: Diabetes Diagnostics Market Forecast (in Million US$), 2015-2020

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

List of Tables Table 2 1: China: Diabetes Epidemiology: Executive Summary Table 2 2: China: Diabetes Market: Executive Summary Table 3 1: Diagnosis of Diabetes Table 4 1: China: Overweight & Obesity Statistics, 2006, 2010 & 2014 Table 4 2: China: Urban & Rural Population Breakup (in Millions), 1991, 2001, 2011 & 2014 Table 4 3: Global: Diabetes Population Breakup by Country (in 000’s), 2014 & 2020 Table 4 4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets Table 5 1: China: Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 2: China (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 3: China (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 4: China (Male & Female): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2007, 2014 & 2020 Table 5 6: China: Total Diagnosed & Drug Treated Diabetes Population, 2007, 2014 & 2020

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia: Email: apac@imarcgroup.com Phone: +91-120-415-5099

IMARC Group North America: Email: america@imarcgroup.com Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa: Email:ema@imarcgroup.com Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/china-diabetes-market

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Š 2015 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing.

International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

http://www.imarcgroup.com Stay With Us:

TELEPHONE: +91-120-4155099 E-MAIL: sales@imarcgroup.com